Adjuvant chemotherapy for rectal cancer

The Lancet Oncology

Volumn 15, Issue 6, 2014, Pages

  Bujko, Krzysztof ^a   Glimelius, Bengt ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HUMAN; LETTER; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RECTUM RESECTION; ABDOMINAL SURGERY; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; FEMALE; MALE; NOTE; RECTUM TUMOR;

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 84899733441     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70071-3     Document Type: Letter

References (4)

1. Bosset JF, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 2014, 15:184-190.
2. Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007, 25:4379-4386.
3. Tiselius C, Gunnarsson U, Smedh K, Glimelius B, Påhlman L Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study. Ann Oncol 2013, 24:160-165.
4. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337. The Cancer Genome Atlas.